Universität Münster
Clinical trials sponsored by Universität Münster, explained in plain language.
-
New drug combo aims to tackle tough lymphoma cases
Disease control Recruiting nowThis study tests whether combining two drugs, loncastuximab tesirine and epcoritamab, can safely and effectively treat people with aggressive B-cell lymphoma that has come back or not responded to prior therapy. The trial will include 120 adults who have either not had CAR-T cell…
Phase: PHASE2 • Sponsor: Universität Münster • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Brain tumor drug repurposed: new combo therapy targets recurrent glioblastoma
Disease control Recruiting nowThis early-stage trial tests a drug called 5-ALA, already used during brain tumor surgery, combined with radiotherapy for people whose glioblastoma has returned. The main goal is to find the safest dose and schedule of this combination. About 34 participants will be enrolled to s…
Phase: PHASE1, PHASE2 • Sponsor: Universität Münster • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New scan aims to uncover hidden breast cancer in early stage patients
Diagnosis Recruiting nowThis study tests a new imaging method called FAPI-PET/MRI to see if it can detect hidden invasive breast cancer in 30 people diagnosed with ductal carcinoma in situ (DCIS), a common pre-stage of breast cancer. Participants receive a weakly radioactive drug and lie in a scanner fo…
Phase: PHASE2 • Sponsor: Universität Münster • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC